C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2004
11/17/2004	EP1476554A1 Novel compound for inhibiting serine proteases and for inhibiting viral infections or viral propagation: rld 8564
11/17/2004	EP1476553A2 Gene for peripheral arterial occlusive disease
11/17/2004	EP1476548A2 Process of cell electrofusion
11/17/2004	EP1476547A2 Targeted chromosomal mutagenesis using zinc finger nucleases
11/17/2004	EP1476546A2 Functionalization of carotenoid compounds
11/17/2004	EP1476545A2 Aggrecanase molecules
11/17/2004	EP1476541A2 Novel cytokine zcytor17 ligand
11/17/2004	EP1476540A1 Methods for producing gama delta t cells
11/17/2004	EP1476539A2 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/17/2004	EP1476537A2 Container with at least one electrode
11/17/2004	EP1476536A1 Systems and methods for rapidly changing the solution environment around sensors
11/17/2004	EP1476469A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
11/17/2004	EP1476462A2 Novel fungal lipase
11/17/2004	EP1476460A2 A nucleic acid encoding a g-protein-coupled receptor; and uses thereof
11/17/2004	EP1476206A1 Compositions comprising undifferentiated fetal cells for the treatment of skin disordes
11/17/2004	EP1476200A2 Compositions and method for regulation of calcium-dependent signalling in brain
11/17/2004	EP1476188A2 Method for accessing microbial diversity
11/17/2004	EP1476185A2 Antibodies to cd40
11/17/2004	EP1476067A2 Novel compositions and methods for cancer
11/17/2004	EP1476063A1 Stem cell and dental pulp harvesting method and apparatus
11/17/2004	EP1476020A1 Pure populations of astrocyte restricted precursor cells and methods for isolation and use thereof
11/17/2004	EP1430111A4 Culture system for rapid expansion of human embryonic stem cells
11/17/2004	EP1180168B1 MOLECULAR CHARACTERISATION OF CHROMOSOME TRANSLOCATION t(11;18)(q21;q21) AND ITS CORRELATION TO CARCINOGENESIS
11/17/2004	EP1178721A4 Process of rapid variety-independent plant transformation
11/17/2004	EP1073733B1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
11/17/2004	EP1064064B1 Removal of contaminants from biological products
11/17/2004	EP1040193B1 Promoter from ashbya gossypii
11/17/2004	EP0990029A4 Phytochrome regulated transcription factor for control of higher plant development
11/17/2004	EP0943003B1 Insulin-like growth factor i (igf-i) expression system and methods of use
11/17/2004	EP0942928B1 Subunit respiratory syncytial virus vaccine preparation
11/17/2004	EP0920501B8 Neuritin, a neurogene
11/17/2004	EP0897392B1 Peptides binding sh3 domain of cortactin and their use
11/17/2004	EP0868524B1 Improved barstar gene
11/17/2004	EP0832185B1 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
11/17/2004	EP0801657B1 Retinoid x receptor-interacting polypeptides and related molecules and methods
11/17/2004	EP0603263B1 Yeast artificial chromosomes and their use in transformation of embryonic stem cells
11/17/2004	CN1547618A Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
11/17/2004	CN1547590A Humanized anti-LT-beta-R antibodies
11/17/2004	CN1547483A New use of ARTEMIN, a member of the GDNF ligand family
11/17/2004	CN1546673A atZA-containing Ti vector construction and transgenic rice preparation method
11/17/2004	CN1546656A Method for adult mesenchymal stem cells in vitro directional induction and differentiation to endothelial cell of blood vessel
11/17/2004	CN1546655A Green fluorescent human liver cancer cell line capable of transfer
11/17/2004	CN1546654A Tissue engineering cartilage construction method using bone matrix gelatin
11/17/2004	CN1546653A Human liver cancer cell line of high lymphatic channel tranfer
11/17/2004	CN1546652A Sakuranetin biosynthesis and uses
11/17/2004	CN1546642A Cell depositing interception device of hematopoietic cell continuous perfusion suspended culture
11/17/2004	CN1546641A Bioreactor of in vitro stem cell culture
11/17/2004	CN1176209C Large scale cultivating inoculation method on animal cell stacking bed
11/17/2004	CN1176208C Process for biologically synthesizing bastardtoadflex extract
11/17/2004	CN1176207C Nerve stem cell culture medium and its preparation method
11/17/2004	CA2470177A1 System and method for controlling user interface properties with data
11/16/2004	US6818812 Inbred corn line G2202
11/16/2004	US6818758 Estrogen receptor beta variants and methods of detection thereof
11/16/2004	US6818757 Nucleotide sequences coding preferential regulatory elements; for use in controlling heart gene expression; for use in induction of embryonic and bone marrow cells; for detection of heart associated differentiation
11/16/2004	US6818756 Polypeptide for use in the generation of disease and stress resistant plants
11/16/2004	US6818755 Nucleic acid molecules encoding 10-deacetylbaccatin III-O-acetyl transferase and related products
11/16/2004	US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
11/16/2004	US6818748 Cloning, expression, sequencing, and functional enhancement of monoclonal ScFv antibody against Venezuelan equine encephalitis virus (VEE)
11/16/2004	US6818746 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and skin disorders
11/16/2004	US6818745 For diagnosis/treatment of tumors; drug screening of antitumor agents; metastatic-tumor excreted phosphaturic-element (mepe/phosphatonin)
11/16/2004	US6818744 For diagnosis/prevention/treatment of neoplasia; antitumor agents
11/16/2004	US6818625 Method for increasing survival rate of cells in animal cell culture under hypoxia condition
11/16/2004	US6818621 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/16/2004	US6818620 Polypeptides
11/16/2004	US6818611 Stabilized bioactive peptides and methods of identification, synthesis and use
11/16/2004	US6818447 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
11/16/2004	US6818446 Compositions and methods for the analysis of mucin gene expression and identification of drugs having the ability to inhibit mucin gene expression
11/16/2004	US6818445 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/16/2004	US6818443 Fluorescent proteins
11/16/2004	US6818426 (R)-2,3-butanediol dehydrogenase
11/16/2004	US6818425 RNA ligase of bacteriophage RM 378
11/16/2004	US6818421 DNA sequences coding for enzymes capable of facilitating the synthesis of linear α-1,4 glucans in plants, fungi and microorganisms
11/16/2004	US6818419 IRAK-4: compositions and methods of use
11/16/2004	US6818392 Monoclonal antibodies to human immunodeficiency virus and uses thereof
11/16/2004	US6818259 Remote plasma discharge process is preferably conducted so that no photons, and particularly no ultraviolet radiation, is transmitted from the plasma glow to the porous article
11/16/2004	US6818230 Antiproliferative effect can be achieved by subjecting conditioned medium obtained by culturing the structures of the invention in culture medium to filtration; anticancer agents
11/16/2004	US6818214 Modulating cell proliferation or apoptosis comprising modulating psoriastatin activity
11/16/2004	US6818210 Introducing non-tumorogenic skeletal myoblasts or cardiomyocytes in myocardial tissue of the animal so as to form a stable myocardial graft, can be used, to deliver recombinant proteins directly to the heart
11/16/2004	CA2298856C Living tissue equivalents
11/16/2004	CA2159109C Therapeutic uses of keratinocyte growth factor
11/16/2004	CA2120342C Epstein-barr virus peptides and antibodies against these peptides
11/16/2004	CA2074719C Calcium channel compositions and methods
11/11/2004	WO2004097039A2 Biosynthetic platform for cardioprotective gene expression using neonatal immature and fetal heart tissue
11/11/2004	WO2004097008A1 Method of generating and isolating tumour cells
11/11/2004	WO2004097006A1 Process for the production of biological substances by perfusion culturing of suspended animal cells
11/11/2004	WO2004097004A2 Trasngenic expression of a phytochrome a gene
11/11/2004	WO2004096995A2 Recombinant plant dicer
11/11/2004	WO2004096990A2 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice
11/11/2004	WO2004096976A2 Spex compositions and methods of use
11/11/2004	WO2004096975A2 Apparatus and methods for amplification of blood stem cell numbers
11/11/2004	WO2004096972A2 Apparatus and methods for amplification of blood stem cell numbers
11/11/2004	WO2004096833A2 Inducers of recombinant protein expression
11/11/2004	WO2004096245A2 Muscle derived cells (mdcs) for promoting and enhancing nerve repair and regeneration
11/11/2004	WO2004096124A2 Compositions and methods for the diagnosis and treatment of tumor
11/11/2004	WO2004096123A2 Methods of promoting cell viability
11/11/2004	WO2004087896A3 Hepatocyte differentiation of stem cells
11/11/2004	WO2004080175A3 Scaffold for cell growth and differentiation
11/11/2004	WO2004072306A8 Preparation of red blood cells with a modified level of blood group antigen expression and their use in the quality control of blood typing reagents
11/11/2004	WO2004071517A3 Uses of il-23 related reagents
11/11/2004	WO2004065554A3 Human saa3 nucleic acid molecule, protein, and methods of use for same

1 ... 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 ... 1827